Alpine Woods Capital Investors’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,145	Closed	-$262K	–	177
2024 Q1	$262K	Hold	1,145	–	–	0.05%	162
2023 Q4	$271K	Sell	1,145 -110	-9%	-$21.6K	0.04%	157
2023 Q3	$246K	Sell	1,255 -135	-10%	-$27.7K	0.04%	152
2023 Q2	$292K	Hold	1,390	–	–	0.05%	142
2023 Q1	$281K	Sell	1,390 -100	-7%	-$22.7K	0.04%	155
2022 Q4	$325K	Hold	1,490	–	–	0.05%	155
2022 Q3	$293K	Hold	1,490	–	–	0.04%	174
2022 Q2	$319K	Hold	1,490	–	–	0.04%	176
2022 Q1	$423K	Sell	1,490 -50	-3%	-$15.4K	0.04%	170
2021 Q4	$580K	Sell	1,540 -155	-9%	-$60.2K	0.06%	167
2021 Q3	$699K	Hold	1,695	–	–	0.07%	163
2021 Q2	$627K	Sell	1,695 -80	-5%	-$26.7K	0.07%	173
2021 Q1	$514K	Sell	1,775 -5,200	-75%	-$1.45M	0.06%	183
2020 Q4	$1.74M	Sell	6,975 -1,300	-16%	-$310K	0.21%	124
2020 Q3	$1.87M	Sell	8,275 -2,050	-20%	-$425K	0.28%	110
2020 Q2	$1.8M	Sell	10,325 -1,075	-9%	-$172K	0.35%	88
2020 Q1	$1.44M	Sell	11,400 -100	-0.9%	-$15K	0.32%	87
2019 Q4	$1.76M	Hold	11,500	–	–	0.33%	72
2019 Q3	$1.52M	Hold	11,500	–	–	0.28%	74
2019 Q2	$1.63M	Hold	11,500	–	–	0.34%	73
2019 Q1	$1.67M	Buy	11,500 +5,100	+80%	+$670K	0.36%	68
2018 Q4	$724K	Hold	6,400	–	–	0.17%	130
2018 Q3	$861K	Sell	6,400 -100	-2%	-$12.3K	0.18%	115
2018 Q2	$730K	Hold	6,500	–	–	0.16%	120
2018 Q1	$694K	Hold	6,500	–	–	0.04%	276
2017 Q4	$711K	Hold	6,500	–	–	0.04%	274
2017 Q3	$702K	Sell	6,500 -9	-0.1%	-$925	0.04%	280
2017 Q2	$658K	Buy	6,509 +9	+0.1%	+$828	0.04%	276
2017 Q1	$585K	Buy	+6,500	New	+$552K	0.03%	294
2015 Q4	–	Sell	-5,000	Closed	-$318K	–	462
2015 Q3	$318K	Buy	+5,000	New	+$359K	0.02%	393